20 Feb

What it takes to be called ‘big pharma’

WRITTEN BY Mike Benson FEATURED IN Industry Overviews

Dividing the industry in two

Companies in the pharmaceutical industry can be classified into one of two segments based on size and market reach. One segment is called “big pharma” and consists of market leaders in the industry. The other consists of small- and medium-sized players.

What it takes to be called ‘big pharma’

The chart above shows the top twelve pharmaceutical companies based on 2013 revenues. Out of the twelve, six companies are headquartered in the United States.

Pharmaceutical companies either deal with patented drugs, generic drugs, or both. Most big pharma companies deal with both. Meanwhile, the majority of revenues are generated from the sale of patented drugs. The global pharmaceutical industry reported total revenues of $980.1 billion in 2013. Of this, approximately 41% was generated in North America (US and Canada) and 27.4% in Europe.

Differences between big pharma and other companies

These are the key features that distinguish big pharma from other pharmaceutical companies:

  • exclusive research and development centers
  • patented products*
  • market reach
  • economies of scale
  • diversified bouquet of products

(*Patented products may also be found in mid-size and small pharmaceutical companies.)

Revenues derived from the sale of patented products make up over 70% of big pharma’s total drug sale revenues. This is why companies spend around 20% of revenues each year on research and development, or R&D, of new drugs. Companies try to fetch maximum returns from a patented drug while its patent is valid. Once the drug is off patent, its price falls to 10%–15% of its original cost.

Big pharma companies have manufacturing units and R&D centers located in multiple countries, as well as wide distribution networks around the world.

Big pharma companies Johnson & Johnson (JNJ), Pfizer (PFE), Merck and Company (MRK), and Gilead Sciences (GILD) together form 30.34% of the Health Care Select Sector SPDR Fund (XLV).

Latest articles

18 Mar

Tilray Reports Its Fourth-Quarter Earnings

WRITTEN BY Adam Jones

Tilray (TLRY) reported its quarterly earnings after the market closed. The company reported a total quarterly sales of $15.5, which increased nearly 203.8% year-over-year.

Earlier today, US tech giant Apple (AAPL) launched new versions of its iPad Air and iPad Mini. The company is set to hold a special event on March 25.

18 Mar

How Facebook Aims to Compete with Twitch

WRITTEN BY Sean Allen

Facebook has stated that over 700 million of its users play games, watch gaming videos, and engage in gaming groups on its platform.

On March 18, President Trump tweeted, “GDP growth during the four quarters of 2018 was the fastest since 2005.” Let’s look at the data.

Today, Steel Dynamics released its first-quarter earnings guidance. It expects its first-quarter EPS to be between $0.88 and $0.92.

18 Mar

Why Amazon Is Interested in YES Network

WRITTEN BY Naomi Gray

Amazon (AMZN) recently teamed up with the Yankees and other investors to purchase the YES Network.